Call Us!

+1 310-279-5152
+1 800-859-7036

 Call 1-800-859-7036 anytime to order or
discuss your options with our oncologists.

Scientific Research:

Scientific Data and Charts

Studies involving blue scorpion serum (an active ingredient in Escozine™).

(The information below is a summary of a laboratory study commissioned by the Cuban pharmacological company, Labiofirm, presented by authors Alexis Diaz, Ph.D., Luis Morier, Yamira Caballero Lorenzo, Sergio Luis Yzquierdo Silverio, Sergio Luis Maestre Mesa, Ph.D.)

An Analysis of the Safety of Blue Scorpion Serum:

Pre-clinical and clinical trials have shown that blue scorpion serum is safe and well-tolerated. High concentrations of blue scorpion serum were administered to mice in preclinical trials repeatedly over an extended period. Even with high concentrations of blue scorpion serum no negative side effects were observed.

During these preclinical trials, scientists recorded the following clinical signs to indicate the effect of blue scorpion serum. These clinical signs include:

1. Normal motor activity
2. Healthy reflexes
3. Response to pain
4. Salivation
5. Sedation/healthy sleep
6. Responsiveness
7. Condition/Appearance of the Skin
8. Condition/Appearance of Mucous Membranes
9. Condition/Appearance of the Eyes
10. Condition/Health of Internal Organs.

Over the course of this study, all animals remained healthy. They maintained healthy weight and levels of activity. No harm was indicated to any of the internal organs of those animals that participated in the study and all were in healthy working order.

In summary, it was scientifically determined that blue scorpion serum showed no toxic side effects.

The Effectiveness of Blue Scorpion Serum as a Pain Killer:

Blue scorpion serum (an active ingredient in Escozine™) was studied in a test of pain suppression. In this study, several groups of mice were given different amounts of blue scorpion serum. Another group was given a powerful, clinically used analgesic (pain killer) called Paracetamol. The control group was untreated - they were neither given blue scorpion serum nor a clinically-used analgesic.

Compared to the control group (which received no pain killer), those participants who were given the clinically used pain killer (Paracetamol) exhibited 47% less pain.  However, those given high concentrations of blue scorpion serum exhibited 55% less pain than those who were not given any pain killers. This indicated in the study that blue scorpion serum diminishes pain by 55%.

Blue Scorpion Serum Relieves Inflammation:

Blue scorpion serum (an active ingredient in Escozine™) was studied in a test of inflammation suppression.  In the study, scientists created three groups of mice. One group was given an anti-inflammatory steroid called Dexamet, often given to cancer patients after chemotherapy. A control group was not given anything. A third group was orally given blue scorpion serum.

All three groups had inflammation artificially induced and were then observed. The level of inflammation was recorded by weighing the participants before and after inflammation was induced.

Compared to the control group that received nothing, those who received blue scorpion serum had up to 38% less inflammation.

From this information, it was concluded that the active ingredient in Escozine™ - blue scorpion serum - significantly reduces inflammation.

Additional information from further clinical trials strongly suggests that at higher dosages than were administered in preclinical trials, blue scorpion serum’s anti-inflammatory activity is enhanced.

Blue Scorpion Serum’s Cancer Fighting Abilities:

Blue scorpion serum inhibits the growth of cancer cell in vitro.  As a part of the study, cancer cells from four different types of cancer were put in test tubes and then exposed to blue scorpion serum.

For all types of cancer used in the study, the number of cancer cells decreased after being exposed to blue scorpion venom. One group decreased by 60% in just one week of exposure.

Blue Scorpion Serum’s Anti-Cancer Effects in the Body:

In this study, five groups had cancerous tumors. One group (the control group) was not given any form of treatment. The other four groups were given different levels of blue scorpion serum.

After several weeks, the size of the tumors was assessed. The high-dose blue scorpion serum group demonstrated a 45% reduction in tumor size relative to control.

From this data, it was concluded that blue scorpion serum inhibits the growth of cancer cells in a living organism.

Images of Cancer Cells in the Body after Being Exposed to Blue Scorpion Serum:

The photos above document the effect of blue scorpion serum upon a cancer tumor. The cellular membranes of these cancer cells were gradually destroyed.

In summary, this study has shown a multitude of beneficial effects related to blue scorpion serum (an active ingredient in Escozine™), as well as significant anti-cancer effects.